CRISPR therapy VERVE-102 reduces cholesterol by 62% after injection https://ymaho.com/crispr-therapy-verve-102-reduces-cholesterol-by-62-after-injection
Journal NEJM published data on the drug VERVE-102: a single CRISPR injection (base editing) reduces LDL by 62% for 18 months without serious side effects. Learn details about the revolutionary therapy.
PDRN serums: how K-beauty is changing anti-age care https://ymaho.com/pdrn-serums-how-k-beauty-is-changing-anti-age-care
PDRN serums instead of injections: why Korean peptides are capturing the mature skin market and what it threatens. Analysis of trends and risks.
Peptide boom: myostimulator creams replace Botox https://ymaho.com/peptide-boom-myostimulator-creams-replace-botox
Creams with peptides mimic the effect of botulinum toxin without injections. Learn about the neurocosmetics boom of 2026: peptide complexes for smoothing wrinkles and home facial rejuvenation.
Fibermaxing: a natural alternative to Ozempic in 2026 https://ymaho.com/fibermaxing-a-natural-alternative-to-ozempic-in-2026
Fibermaxing — the 2026 trend: how fiber is replacing GLP-1 injections and changing the market. Find out who is making money and who is threatened by the new dietary standard.
AI visualization is changing the market of invasive cosmetology and trust https://ymaho.com/ai-visualization-is-changing-the-market-of-invasive-cosmetology-and-trust
84% of patients are more confident with AI visualization before injections. How technology is changing the cosmetology market, trust, and insurance companies. Read more.
Acupuncture Instead of Botox: Mira Kapur's New Procedure https://ymaho.com/acupuncture-instead-of-botox-mira-kapur-s-new-procedure
Viral Trend of Cosmetic Acupuncture by Mira Kapur: Natural Lifting Without Injections. Learn the Risks, Cost, and Forecasts. Read Now!
CRISPR bacteria for short bowel syndrome: Nature Medicine result https://ymaho.com/crispr-bacteria-for-short-bowel-syndrome-nature-medicine-result
Researchers have used a CRISPR-modified bacterium for the first time to replace daily injections in short bowel syndrome. Reduce dependence on IV drips. Read the breakthrough analysis.
Gene therapy for OTOF deafness: hearing restoration https://ymaho.com/gene-therapy-for-otof-deafness-hearing-restoration
FDA approved the first gene therapy for hereditary deafness Otarmeni. Learn how a single injection restores hearing in OTOF mutation and changes the market.
Cholesterol gene therapy VERVE-102: NEJM data, LDL reduction by 62% https://ymaho.com/cholesterol-gene-therapy-verve-102-nejm-data-ldl-reduction-by-62
NEJM published phase 1b results of gene therapy VERVE-102: LDL reduction by 62% after a single injection. Analysis of efficacy, risks, and prospects for patients with hypercholesterolemia. Read more.
FDA approved the first gene therapy for hereditary deafness https://ymaho.com/fda-approved-the-first-gene-therapy-for-hereditary-deafness
Regeneron's Otarmeni restores hearing to normal in 42% of patients. The therapy treats OTOF gene mutations with a single injection. Learn how AAV vector technology has for the first time restored the ability to hear a whisper.